Early life environment and natural history of inflammatory bowel diseases

BMC Gastroenterology

Volumn 14, Issue 1, 2014, Pages

  Guo, Abra Y ^a   Stevens, Betsy W ^a   Wilson, Robin G ^a   Russell, Caitlin N ^a   Cohen, Melissa A ^a   Sturgeon, Holly C ^a   Thornton, Anna ^a   Giallourakis, Cosmas ^a,b   Khalili, Hamed ^a,b   Nguyen, Deanna D ^a,b   Sauk, Jenny ^a,b   Yajnik, Vijay ^a,b   Xavier, Ramnik J ^a,b   Ananthakrishnan, Ashwin N ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Breastfeeding; Crohn's disease; Early life; Microbiome; Surgery

Indexed keywords

BIOLOGICAL PRODUCT; CIGARETTE SMOKE; PASSIVE SMOKING;

ADULT; ARTICLE; BREAST FEEDING; CROHN DISEASE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; EARLY LIFE STRESS; ENVIRONMENTAL EXPOSURE; FAMILY HISTORY; FEMALE; HUMAN; INFLAMMATORY BOWEL DISEASE; INTESTINE SURGERY; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; ONSET AGE; PANCOLITIS; PROSPECTIVE STUDY; RISK REDUCTION; SURGICAL RISK; ULCERATIVE COLITIS; ADVERSE EFFECTS; COLITIS, ULCERATIVE; PASSIVE SMOKING; QUESTIONNAIRE; REGISTER; RISK FACTOR; UNITED STATES;

BREAST FEEDING; COLITIS, ULCERATIVE; CROHN DISEASE; DISEASE PROGRESSION; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; MALE; MASSACHUSETTS; PROSPECTIVE STUDIES; REGISTRIES; RISK FACTORS; SURVEYS AND QUESTIONNAIRES; TOBACCO SMOKE POLLUTION;

EID: 84964316164     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/s12876-014-0216-8     Document Type: Article

References (47)

1. Khor B, Gardet A, Xavier RJ: Genetics and pathogenesis of inflammatory bowel disease. Nature 2011, 474(7351):307-317.
2. Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, Hui KY, Lee JC, Schumm LP, Sharma Y, Anderson CA, Essers J, Mitrovic M, Ning K, Cleynen I, Theatre E, Spain SL, Raychaudhuri S, Goyette P, Wei Z, Abraham C, Achkar JP, Ahmad T, Amininejad L, Ananthakrishnan AN, Andersen V, Andrews JM, Baidoo L, Balschun T, Bampton PA, Bitton A, et al: Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 2012, 491(7422):119-124.
3. Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G, Benchimol EI, Panaccione R, Ghosh S, Barkema HW, Kaplan GG: Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012, 142(1):46-54. e42; quiz e30.
4. Cosnes J, Gower-Rousseau C, Seksik P, Cortot A: Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology 2011, 140(6):1785-1794.
5. Williams CN: Does the incidence of IBD increase when persons move from a low-to a high-risk area? Inflamm Bowel Dis 2008, 14(Suppl 2):S41-42.
6. Gevers D, Kugathasan S, Denson LA, Vázquez-Baeza Y, Van Treuren W, Ren B, Schwager E, Knights D, Song SJ, Yassour M, Morgan XC, Kostic AD, Luo C, González A, McDonald D, Haberman Y, Walters T, Baker S, Rosh J, Stephens M, Heyman M, Markowitz J, Baldassano R, Griffiths A, Sylvester F, Mack D, Kim S, Crandall W, Hyams J, Huttenhower C, Knight R, Xavier RJ: The treatment-naive microbiome in new-onset Crohn's disease. Cell Host Microbe 2014, 15(3):382-392.
7. Kostic AD, Xavier RJ, Gevers D: The microbiome in inflammatory bowel disease: current status and the future ahead. Gastroenterology 2014, 146(6):1489-1499.
8. Morgan XC, Tickle TL, Sokol H, Gevers D, Devaney KL, Ward DV, Reyes JA, Shah SA, LeLeiko N, Snapper SB, Bousvaros A, Korzenik J, Sands BE, Xavier RJ, Huttenhower C: Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol 2012, 13(9):R79.
9. Sokol H, Pigneur B, Watterlot L, Lakhdari O, Bermudez-Humaran LG, Gratadoux JJ, Blugeon S, Bridonneau C, Furet JP, Corthier G, Grangette C, Vasquez N, Pochart P, Trugnan G, Thomas G, Blottière HM, Doré J, Marteau P, Seksik P, Langella P: Faecalibacterium prausnitzii is an antiinflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A 2008, 105(43):16731-16736.
10. Darfeuille-Michaud A, Boudeau J, Bulois P, Neut C, Glasser AL, Barnich N, Bringer MA, Swidsinski A, Beaugerie L, Colombel JF: High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology 2004, 127(2):412-421.
11. Ananthakrishnan AN: Environmental risk factors for inflammatory bowel disease. Gastroenterol Hepatol 2013, 9(6):367-374.
12. Hansen TS, Jess T, Vind I, Elkjaer M, Nielsen MF, Gamborg M, Munkholm P: Environmental factors in inflammatory bowel disease: a case-control study based on a Danish inception cohort. J Crohn's Colitis 2011, 5(6):577-584.
13. Hlavaty T, Toth J, Koller T, Krajcovicova A, Oravcova S, Zelinkova Z, Huorka M: Smoking, breastfeeding, physical inactivity, contact with animals, and size of the family influence the risk of inflammatory bowel disease: A Slovak case-control study. United Eur Gastroenterol J 2013, 1(2):109-119.
14. Bager P, Simonsen J, Nielsen NM, Frisch M: Cesarean section and offspring's risk of inflammatory bowel disease: a national cohort study. Inflamm Bowel Dis 2012, 18(5):857-862.
15. Decker E, Engelmann G, Findeisen A, Gerner P, Laass M, Ney D, Posovszky C, Hoy L, Hornef MW: Cesarean delivery is associated with celiac disease but not inflammatory bowel disease in children. Pediatrics 2010, 125(6):e1433-1440.
16. Khalili H, Ananthakrishnan AN, Higuchi LM, Richter JM, Fuchs CS, Chan AT: Early life factors and risk of inflammatory bowel disease in adulthood. Inflamm Bowel Dis 2013, 19(3):542-547.
17. Kronman MP, Zaoutis TE, Haynes K, Feng R, Coffin SE: Antibiotic exposure and IBD development among children: a population-based cohort study. Pediatrics 2012, 130(4):e794-803.
18. Shaw SY, Blanchard JF, Bernstein CN: Association between the use of antibiotics in the first year of life and pediatric inflammatory bowel disease. Am J Gastroenterol 2010, 105(12):2687-2692.
19. Ng SC, Tang W, Leong RW, Chen M, Ko Y, Studd C, Niewiadomski O, Bell S, Kamm MA, de Silva HJ, Kasturiratne A, Senanayake YU, Ooi CJ, Ling KL, Ong D, Goh KL, Hilmi I, Ouyang Q, Wang YF, Hu P, Zhu Z, Zeng Z, Wu K, Wang X, Xia B, Li J, Pisespongsa P, Manatsathit S, Aniwan S, Simadibrata M et al: Environmental risk factors in inflammatory bowel disease: a population-based case-control study in Asia-Pacific. Gut 2014.
20. Goldman AS: The immune system in human milk and the developing infant. Breastfeed Med 2007, 2(4):195-204.
21. Hanson LA: Session 1: Feeding and infant development breast-feeding and immune function. Proc Nutr Soc 2007, 66(3):384-396.
22. Rogier EW, Frantz AL, Bruno ME, Wedlund L, Cohen DA, Stromberg AJ, Kaetzel CS: Secretory antibodies in breast milk promote long-term intestinal homeostasis by regulating the gut microbiota and host gene expression. Proc Natl Acad Sci U S A 2014, 111(8):3074-3079.
23. Satsangi J, Silverberg MS, Vermeire S, Colombel JF: The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 2006, 55(6):749-753.
24. Strachan DP: Hay fever, hygiene, and household size. BMJ 1989, 299(6710):1259-1260.
25. Castiglione F, Diaferia M, Morace F, Labianca O, Meucci C, Cuomo A, Panarese A, Romano M, Sorrentini I, D'Onofrio C, Caporaso N, Rispo A: Risk factors for inflammatory bowel diseases according to the "hygiene hypothesis": a case-control, multi-centre, prospective study in Southern Italy. J Crohns Colitis 2012, 6(3):324-329.
26. Jakobsen C, Paerregaard A, Munkholm P, Wewer V: Environmental factors and risk of developing paediatric inflammatory bowel disease-a population based study 2007-2009. J Crohns Colitis 2013, 7(1):79-88.
27. Roberts SE, Wotton CJ, Williams JG, Griffith M, Goldacre MJ: Perinatal and early life risk factors for inflammatory bowel disease. World J Gastroenterol 2011, 17(6):743-749.
28. Gearry RB, Richardson AK, Frampton CM, Dodgshun AJ, Barclay ML: Population-based cases control study of inflammatory bowel disease risk factors. J Gastroenterol Hepatol 2010, 25(2):325-333.
29. Corrao G, Tragnone A, Caprilli R, Trallori G, Papi C, Andreoli A, Di Paolo M, Riegler G, Rigo GP, Ferrau O, Mansi C, Ingrosso M, Valpiani D: Risk of inflammatory bowel disease attributable to smoking, oral contraception and breastfeeding in Italy: a nationwide case-control study. Cooperative Investigators of the Italian Group for the Study of the Colon and the Rectum (GISC). Int J Epidemiol 1998, 27(3):397-404.
30. Penders J, Thijs C, Vink C, Stelma FF, Snijders B, Kummeling I, van den Brandt PA, Stobberingh EE: Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics 2006, 118(2):511-521.
31. Azad MB, Konya T, Maughan H, Guttman DS, Field CJ, Chari RS, Sears MR, Becker AB, Scott JA, Kozyrskyj AL: Gut microbiota of healthy Canadian infants: profiles by mode of delivery and infant diet at 4 months. CMAJ 2013, 185(5):385-394.
32. Fallani M, Young D, Scott J, Norin E, Amarri S, Adam R, Aguilera M, Khanna S, Gil A, Edwards CA, Dore J: Intestinal microbiota of 6-week-old infants across Europe: geographic influence beyond delivery mode, breastfeeding, and antibiotics. J Pediatr Gastroenterol Nutr 2010, 51(1):77-84.
33. Penders J, Thijs C, van den Brandt PA, Kummeling I, Snijders B, Stelma F, Adams H, van Ree R, Stobberingh EE: Gut microbiota composition and development of atopic manifestations in infancy: the KOALA Birth Cohort Study. Gut 2007, 56(5):661-667.
34. Van Nimwegen FA, Penders J, Stobberingh EE, Postma DS, Koppelman GH, Kerkhof M, Reijmerink NE, Dompeling E, van den Brandt PA, Ferreira I, Mommers M, Thijs C: Mode and place of delivery, gastrointestinal microbiota, and their influence on asthma and atopy. J Allergy Clin Immunol 2011, 128(5):e941-943.
35. Birrenbach T, Bocker U: Inflammatory bowel disease and smoking: a review of epidemiology, pathophysiology, and therapeutic implications. Inflamm Bowel Dis 2004, 10(6):848-859.
36. Cosnes J: Tobacco and IBD: relevance in the understanding of disease mechanisms and clinical practice. Best Pract Res Clin Gastroenterol 2004, 18(3):481-496.
37. Cosnes J: What is the link between the use of tobacco and IBD? Inflamm Bowel Dis 2008, 14(Suppl 2):S14-15.
38. Cosnes J, Carbonnel F, Beaugerie L, Le Quintrec Y, Gendre JP: Effects of cigarette smoking on the long-term course of Crohn's disease. Gastroenterology 1996, 110(2):424-431.
39. Cosnes J, Beaugerie L, Carbonnel F, Gendre JP: Smoking cessation and the course of Crohn's disease: an intervention study. Gastroenterology 2001, 120(5):1093-1099.
40. Cosnes J, Carbonnel F, Carrat F, Beaugerie L, Cattan S, Gendre J: Effects of current and former cigarette smoking on the clinical course of Crohn's disease. Aliment Pharmacol Ther 1999, 13(11):1403-1411.
41. van der Heide F, Dijkstra A, Weersma RK, Albersnagel FA, van der Logt EM, Faber KN, Sluiter WJ, Kleibeuker JH, Dijkstra G: Effects of active and passive smoking on disease course of Crohn's disease and ulcerative colitis. Inflamm Bowel Dis 2009, 15(8):1199-1207.
42. Mahid SS, Minor KS, Stromberg AJ, Galandiuk S: Active and passive smoking in childhood is related to the development of inflammatory bowel disease. Inflamm Bowel Dis 2007, 13(4):431-438.
43. Sandler RS, Sandler DP, McDonnell CW, Wurzelmann JI: Childhood exposure to environmental tobacco smoke and the risk of ulcerative colitis. Am J Epidemiol 1992, 135(6):603-608.
44. Benjamin JL, Hedin CR, Koutsoumpas A, Ng SC, McCarthy NE, Prescott NJ, Pessoa-Lopes P, Mathew CG, Sanderson J, Hart AL, Kamm MA, Knight SC, Forbes A, Stagg AJ, Lindsay JO, Whelan K: Smokers with active Crohn's disease have a clinically relevant dysbiosis of the gastrointestinal microbiota. Inflamm Bowel Dis 2012, 18(6):1092-1100.
45. Munyaka PM, Khafipour E, Ghia JE: External influence of early childhood establishment of gut microbiota and subsequent health implications. Front Pediatrics 2014, 2:109.
46. Bergeron V, Grondin V, Rajca S, Maubert MA, Pigneur B, Thomas G, Trugnan G, Beaugerie L, Cosnes J, Masliah J, Sokol H, Seksik P, Bachelet M: Current smoking differentially affects blood mononuclear cells from patients with Crohn's disease and ulcerative colitis: relevance to its adverse role in the disease. Inflamm Bowel Dis 2012, 18(6):1101-1111.
47. Alegria-Torres JA, Baccarelli A, Bollati V: Epigenetics and lifestyle. Epigenomics 2011, 3(3):267-277.